Comparing Treatments for Multiple Myeloma

NCT00001750 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Stemgen

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)